S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
Is CRISPR Therapeutics the NVIDIA of gene editing?
Critical asset just had biggest fall on record (Ad)
3 Chinese stocks poised for rebound
4 stocks benefitting from NVIDIA's explosive growth
Critical asset just had biggest fall on record (Ad)
These 2 carnivore dining stocks gaining on the Ozempic craze
This healthcare stock making a buzz with 160% growth
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
First it was Tyson stock, now this food company is set to rally
6 reasons to buy Teva Pharmaceuticals stock sooner than later
S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
Is CRISPR Therapeutics the NVIDIA of gene editing?
Critical asset just had biggest fall on record (Ad)
3 Chinese stocks poised for rebound
4 stocks benefitting from NVIDIA's explosive growth
Critical asset just had biggest fall on record (Ad)
These 2 carnivore dining stocks gaining on the Ozempic craze
This healthcare stock making a buzz with 160% growth
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
First it was Tyson stock, now this food company is set to rally
6 reasons to buy Teva Pharmaceuticals stock sooner than later
S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
Is CRISPR Therapeutics the NVIDIA of gene editing?
Critical asset just had biggest fall on record (Ad)
3 Chinese stocks poised for rebound
4 stocks benefitting from NVIDIA's explosive growth
Critical asset just had biggest fall on record (Ad)
These 2 carnivore dining stocks gaining on the Ozempic craze
This healthcare stock making a buzz with 160% growth
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
First it was Tyson stock, now this food company is set to rally
6 reasons to buy Teva Pharmaceuticals stock sooner than later
S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
Is CRISPR Therapeutics the NVIDIA of gene editing?
Critical asset just had biggest fall on record (Ad)
3 Chinese stocks poised for rebound
4 stocks benefitting from NVIDIA's explosive growth
Critical asset just had biggest fall on record (Ad)
These 2 carnivore dining stocks gaining on the Ozempic craze
This healthcare stock making a buzz with 160% growth
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
First it was Tyson stock, now this food company is set to rally
6 reasons to buy Teva Pharmaceuticals stock sooner than later
LON:GETB

GetBusy (GETB) Share Price, News & Analysis

GBX 66
0.00 (0.00%)
(As of 02/26/2024 09:21 PM ET)
Today's Range
65
67
50-Day Range
62
73
52-Week Range
52
79.81
Volume
100 shs
Average Volume
33,686 shs
Market Capitalization
£33.38 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About GetBusy

GetBusy plc, through its subsidiaries, develops and sells document and task management software products in the United Kingdom, the United States, Australia, and New Zealand. It offers Workiro; Virtual Cabinet; SmartVault; and Certified Vault. The company also provides a range of tools and end -to -end workflows such as digital asset and document management, tailored templates, quotes/proposal development, form-fill, authentication, e-signatures and approvals, workflow and task management, chat, and complex digital certification. The company was incorporated in 2017 and is based in Cambridge, the United Kingdom.

GETB Stock Price History

GETB Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com
Receive GETB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GetBusy and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
7/23/2020
Today
2/27/2024

Industry, Sector and Symbol

Industry
Software - Application
Sub-Industry
N/A
CIK
N/A
Phone
N/A
Fax
N/A
Employees
144
Year Founded
N/A

Profitability

Net Income
£-1,370,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£20.74 million
Cash Flow
GBX 4.64 per share
Book Value
GBX (7) per share

Miscellaneous

Free Float
N/A
Market Cap
£33.38 million
Optionable
Not Optionable
Beta
0.33
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

  • Mr. Daniel Adam Rabie (Age 38)
    CEO & Executive Director
    Comp: $477k
  • Mr. Jonathan Paul-Crichton Haworth (Age 43)
    CFO, Company Secretary & Executive Director
    Comp: $349k
  • Ms. Dania Buchanan
    President
  • Mr. Ben James Oliver (Age 42)
    Chief Technology Officer
  • Mr. Jason Ross
    Chief Information Officer
  • - Sophie
    Marketing Manager
  • Ms. Gael Norris
    Chief People & Culture Officer
  • Mr. Matthew David Butler (Age 40)
    Head of GetBusy
  • Mr. Alex Kowalski
    Co-Head of Virtual Cabinet
  • Mr. David Owen
    Co-Head of Virtual Cabinet














GETB Stock Analysis - Frequently Asked Questions

How have GETB shares performed in 2024?

GetBusy's stock was trading at GBX 66 on January 1st, 2024. Since then, GETB shares have increased by 0.0% and is now trading at GBX 66.
View the best growth stocks for 2024 here
.

How were GetBusy's earnings last quarter?

GetBusy plc (LON:GETB) released its quarterly earnings data on Thursday, July, 23rd. The company reported $1.64 EPS for the quarter.

How do I buy shares of GetBusy?

Shares of GETB stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:GETB) was last updated on 2/27/2024 by MarketBeat.com Staff